000130891 001__ 130891
000130891 005__ 20240228145557.0
000130891 0247_ $$2doi$$a10.18632/oncotarget.18583
000130891 0247_ $$2WOS$$aWOS:000413077800043
000130891 0247_ $$2altmetric$$aaltmetric:21320660
000130891 0247_ $$2pmid$$apmid:28642448
000130891 037__ $$aDKFZ-2017-05967
000130891 082__ $$a610
000130891 1001_ $$aMoreno, Natalia$$b0
000130891 245__ $$aCombined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
000130891 260__ $$a[S.l.]$$bImpact Journals LLC$$c2017
000130891 3367_ $$2DRIVER$$aarticle
000130891 3367_ $$2DataCite$$aOutput Types/Journal article
000130891 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1525778274_9525
000130891 3367_ $$2BibTeX$$aARTICLE
000130891 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000130891 3367_ $$00$$2EndNote$$aJournal Article
000130891 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000130891 588__ $$aDataset connected to Web of Science, Web of Science, , CrossRef
000130891 7001_ $$aHolsten, Till$$b1
000130891 7001_ $$aMertins, Julius$$b2
000130891 7001_ $$aZhogbi, Annabelle$$b3
000130891 7001_ $$0P:(DE-He78)3fdc3623477264cb5d0e14f256dbfbb8$$aJohann, Pascal$$b4$$udkfz
000130891 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b5$$udkfz
000130891 7001_ $$aMeisterernst, Michael$$b6
000130891 7001_ $$aKerl, Kornelius$$b7
000130891 773__ $$0PERI:(DE-600)2560162-3$$a10.18632/oncotarget.18583$$gVol. 8, no. 49, p. 84986 - 84995$$n49$$p84986 - 84995$$tOncoTarget$$v8$$x1949-2553$$y2017
000130891 909CO $$ooai:inrepo02.dkfz.de:130891$$pVDB
000130891 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3fdc3623477264cb5d0e14f256dbfbb8$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000130891 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000130891 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000130891 9141_ $$y2017
000130891 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOTARGET : 2015
000130891 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000130891 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000130891 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000130891 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000130891 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000130891 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000130891 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000130891 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bONCOTARGET : 2015
000130891 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x0
000130891 980__ $$ajournal
000130891 980__ $$aVDB
000130891 980__ $$aI:(DE-He78)B062-20160331
000130891 980__ $$aUNRESTRICTED